Michael Ackermann, Director at Tarsus Pharmaceuticals, Inc. (TARS), sold 10,329 shares at $23.85 ($253K) on 2021-12-01, disclosed to the SEC on 2021-12-03.
Open-market sale of $253k TARS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.85 | 2,442 | $58K | 23.0% |
| 2 | $23.85 | 2,442 | $58K | 23.0% |
| 3 | $24.68 | 2,054 | $51K | 20.0% |
| 4 | $24.68 | 2,054 | $51K | 20.0% |
| 5 | $25.87 | 809 | $21K | 8.3% |
| 6 | $26.65 | 528 |
| $14K |
| 5.6% |
| Total | $24.48 avg | 10,329 | $253K | 100% |
| Filing → |
| TARS | SELL | 2021-10-14 | $267K | — | Filing → |
| TARS | SELL | 2021-10-12 | $5K | — | Filing → |
| TARS | SELL | 2021-09-03 | $294K | — | Filing → |